Conditions: Advanced Solid Tumor
Interventions: Drug: M3554
Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany
Not yet recruiting
Feeds
32835 items (32835 unread) in 74 feeds
Acinar Cell Carcinoma
(486 unread)
Acinic Cell Carcinoma
(299 unread)
Adenoid Cystic Carcinoma
(550 unread)
Adrenal Gland Cancer
(2410 unread)
Ampulla Of Vater
(469 unread)
Anal Cancer
(2709 unread)
Angiosarcoma
(990 unread)
Appendix Cancer
(684 unread)
Bile Duct Cancer
(4355 unread)
Brain and CNS
(6120 unread)
Carcinoid
(887 unread)
Endocrine/Neuroendocrine
(5825 unread)
Gall Bladder Cancer
(1132 unread)
Hemangioendothelioma
(1176 unread)
Hepatoblastoma
(770 unread)
Pancreas
(563 unread)
Phyllodes
(384 unread)
PMP and Mucinous Tumors
(477 unread)
Rhabdomyosarcoma
(1118 unread)
Sarcoma
(1431 unread)
Trial - Sarcoma (100 unread)
1
2
-
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Posted: October 15th, 2024, 11:00pm UTC
-
Agnostic Therapy in Rare Solid Tumors
Posted: October 14th, 2024, 11:00pm UTC
Conditions: Urachal Cancer; Parathyroid Carcinoma; Fibrolamellar Carcinoma; Angiosarcoma; Secretory Carcinoma of Breast; Anal Neoplasms; Metaplastic Breast Carcinoma; Translocation Renal Cell Carcinoma; Carcinosarcoma; Small Intestine Neoplasms; Cholangiocarcinoma; Sertoli-Leydig Cell Tumor; Adenoid Cystic Carcinoma; Mesothelioma; Neuroblastoma; Adrenal Gland Neoplasms; Penile Neoplasms; Apocrine Carcinoma; Fibrosarcoma; Cancer of Unknown Primary; Hemangioblastoma; Thyroid Neoplasms; Hepatoblastoma; Fallopian Tube Neoplasms; Leiomyosarcoma; Vaginal Neoplasms; Neurofibrosarcoma; Gallbladder Neoplasms; Osteosarcoma; Biliary Tract Neoplasms; Clear Cell Endometrial Cancer; Yolk Sac Tumor; Vulvar Neoplasms; Kaposi Sarcoma; Ovarian Epithelial Cancer; Soft Tissue Sarcoma; Urethral Neoplasms; Granulosa Cell Tumor; Primitive Neuroectodermal Tumor; Neuroendocrine Tumors; Trophoblastic Tumor
Interventions: Drug: Nivolumab
Sponsors: Instituto do Cancer do Estado de São Paulo; Financiadora de Estudos e Projetos
Recruiting -
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Posted: October 14th, 2024, 11:00pm UTC
Conditions: Advanced Fallopian Tube Carcinoma; Advanced Fallopian Tube High Grade Serous Adenocarcinoma; Advanced Ovarian Carcinoma; Advanced Ovarian Carcinosarcoma; Advanced Ovarian Clear Cell Adenocarcinoma; Advanced Ovarian Endometrioid Adenocarcinoma; Advanced Ovarian High Grade Serous Adenocarcinoma; Advanced Primary Peritoneal Carcinoma; Advanced Primary Peritoneal High Grade Serous Adenocarcinoma; Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma; FIGO Stage III Ovarian Cancer 2014; FIGO Stage IV Ovarian Cancer 2014; Ovarian Mixed Cell Adenocarcinoma; Primary Peritoneal Carcinosarcoma; Primary Peritoneal Clear Cell Adenocarcinoma; Primary Peritoneal Endometrioid Adenocarcinoma
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed; Procedure: Leukapheresis; Procedure: Magnetic Resonance Imaging; Biological: Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine; Drug: Placebo Administration; Biological: Tetanus and Diphtheria Toxoids Adsorbed
Sponsors: Mayo Clinic
Not yet recruiting -
Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
Posted: October 11th, 2024, 11:00pm UTC
Conditions: Sarcoma,Soft Tissue; Sarcoma; Sarcoma of Bone
Interventions: Drug: Chidamide Tablets combined with AK112
Sponsors: Shanxi Province Cancer Hospital
Recruiting -
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced, Recurrent Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
Posted: October 8th, 2024, 11:00pm UTC
Conditions: Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Carcinoma; Advanced Sarcoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Recurrent Breast Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Pancreatic Carcinoma; Recurrent Prostate Carcinoma; Recurrent Sarcoma; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8
Interventions: Drug: Abemaciclib; Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Carboplatin; Procedure: Echocardiography; Drug: Exemestane; Drug: Fulvestrant; Drug: Gefitinib; Drug: Gemcitabine; Drug: Letrozole; Procedure: Multigated Acquisition Scan; Drug: Olaparib; Drug: Osimertinib; Drug: Paclitaxel; Drug: Pegylated Liposomal Doxorubicin Hydrochloride; Drug: Pemetrexed; Other: Survey Administration; Drug: Tamoxifen; Drug: Temozolomide
Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; AstraZeneca; Eli Lilly and Company
Not yet recruiting -
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Posted: October 3rd, 2024, 11:00pm UTC
Conditions: Neuroblastoma; Rhabdomyosarcoma; Synovial Sarcoma; Peripheral Nerve Sheath Tumors; Clear Cell Sarcoma; Alveolar Soft Part Sarcoma; Desmoplastic Small Round Cell Tumor; Chordoma; Rhabdoid Tumor; Epithelioid Sarcoma; Myoepithelial Tumor; Osteosarcoma; Ewing Sarcoma
Interventions: Device: Miltenyi CliniMACS Prodigy ® system; Drug: Zoledronic acid
Sponsors: University of Florida
Not yet recruiting -
Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel
Posted: September 27th, 2024, 11:00pm UTC
Conditions: Synovial Sarcoma; Myxoid Liposarcoma
Interventions: Genetic: Non-conforming afamitresgene autoleucel
Sponsors: Adaptimmune
Available -
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Posted: September 25th, 2024, 11:00pm UTC
Conditions: Ovarian Cancer; Endometrial Cancer; Breast Cancer; Lymphoma; Malignant Melanoma; Sarcoma
Sponsors: Region Skane; Linkoeping University; VOC Diagnostics
Recruiting -
Treatment Outcomes of Retroperitoneal Sarcoma
Posted: September 25th, 2024, 11:00pm UTC
Conditions: Retroperitoneal Sarcoma
Interventions: Procedure: tumor wide excision
Sponsors: Taichung Veterans General Hospital
Active, not recruiting -
Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib
Posted: September 24th, 2024, 11:00pm UTC
Conditions: BRAF V600E Mutation
Interventions: Drug: Plixorafenib
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fore Biotherapeutics; Ivy Brain Tumor Foundation
Not yet recruiting -
NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
Posted: September 24th, 2024, 11:00pm UTC
Conditions: Dermatofibrosarcoma Protuberans (DFSP); Skin Squamous Cell Carcinoma
Interventions: Drug: ICG administration; Drug: ICG administration; Drug: ICG administration; Drug: ICG administration
Sponsors: The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; 1〠Department of Plastic and Reconstructive Surgery, Peking University Third Hospital; 2〠Department of Plastic and Reconstructive Surgery, 1st Medical Center of Chinese PLA General Hospital; 3〠Department of Plastic and Reconstructive Surgery, Peking University International Hospital
Not yet recruiting -
Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy
Posted: September 19th, 2024, 11:00pm UTC
Conditions: Bone and Soft Tissue Tumors
Sponsors: Istituto Ortopedico Rizzoli; Università Degli Studi del Sannio Dipartimento di Ingegneria Benevento; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Meldola
Recruiting -
Using CICS-1 and SPM-011 and ï¼»18Fï¼½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Posted: September 19th, 2024, 11:00pm UTC
Conditions: Thoracic Solid Malignant Tumor
Interventions: Radiation: BNCT; Diagnostic Test: ï¼»18Fï¼½FBPA
Sponsors: Stella Pharma Corporation; Cancer Intelligence Care Systems, Inc.; Sumitomo Heavy Industries, Ltd.
Not yet recruiting -
The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities
Posted: September 13th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcomas
Interventions: Radiation: Hypofractionated Radiotherapy; Drug: 3 cycles of AI
Sponsors: Fujian Medical University Union Hospital
Recruiting -
UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT
Posted: September 2nd, 2024, 11:00pm UTC
Conditions: Uterine Sarcoma; Vulvar Cancer; Non Epithelial Ovarian Cancers (NEOC)
Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting -
XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
Posted: August 26th, 2024, 11:00pm UTC
Conditions: Metastatic Leiomyosarcoma; Unresectable Leiomyosarcoma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography; Procedure: Multigated Acquisition Scan; Drug: Zanzalintinib
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet recruiting -
Phisical Activity and Sarcoma, Role and Impact on Outcome
Posted: August 22nd, 2024, 11:00pm UTC
Conditions: Sarcoma
Sponsors: European Institute of Oncology
Not yet recruiting -
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
Posted: August 22nd, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma; Primary Central Nervous System Carcinoma; Melanoma; Rhabdomyosarcoma; Ewing Sarcoma
Interventions: Biological: LN-145/LN-144
Sponsors: Iovance Biotherapeutics, Inc.
Recruiting -
A Phase II Study in Adolescents With Advanced Ewing Sarcoma
Posted: August 21st, 2024, 11:00pm UTC
Conditions: Ewing Sarcoma
Interventions: Drug: KC1036
Sponsors: Beijing Konruns Pharmaceutical Co., Ltd.
Recruiting -
Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma
Posted: August 20th, 2024, 11:00pm UTC
Conditions: Osteosarcoma; Bone Cancer
Interventions: Drug: intra-arterial cisplatin plus anti-angiogenesis inhibitor rh-endostatin (Endostar)
Sponsors: Shanghai 6th People's Hospital
Not yet recruiting -
Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors
Posted: August 13th, 2024, 11:00pm UTC
Conditions: Sarcoma, Soft Tissue; Sarcoma, Spindle Cell
Interventions: Device: Biodegradable Magnesium Metal Clips
Sponsors: Guangdong Provincial People's Hospital
Not yet recruiting -
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor
Posted: August 13th, 2024, 11:00pm UTC
Conditions: Urothelial Carcinoma; Breast Neoplasms; Lung Cancer; Gastric Cancer; Soft Tissue Sarcoma; Other Carcinoma
Interventions: Drug: Pemigatinib
Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting -
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Posted: August 7th, 2024, 11:00pm UTC
Conditions: Neuroblastoma Recurrent; Ewing's Sarcoma Recurrent; Osteosarcoma Recurrent; Rhabdomyosarcoma Recurrent; Liposarcoma Recurrent
Interventions: Drug: Silmitasertib; Drug: Irinotecan; Drug: Temozolomide; Drug: Vincristine
Sponsors: Milton S. Hershey Medical Center
Not yet recruiting -
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Posted: August 7th, 2024, 11:00pm UTC
Conditions: Hepatocholangiocarcinoma; Fibrolamellar Carcinoma; Hepatic Epithelioid Hemangioendothelioma; Hepatoblastoma; Hepatic Neuroendocrine Carcinoma; Hepatic Carcinosarcomas; Hepatic Cystadenoma; Hepatic Leiomyosarcomas; Hepatic Angiosarcomas; Cholangiocarcinoma
Sponsors: Federation Francophone de Cancerologie Digestive; Société Nationale Française de Gastroentérologie
Recruiting -
89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma
Posted: August 5th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma
Interventions: Drug: 89Zr-DFOsq-olaratumab (89Zr-TLX300-CDx)
Sponsors: Telix Pharmaceuticals (Innovations) Pty Ltd
Not yet recruiting -
Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE
Posted: August 2nd, 2024, 11:00pm UTC
Conditions: Cancer; Cystic Carcinomas, Adenoid; Soft-tissue Sarcomas; Rhabdomyosarcoma Pleomorphic; Sarcoma,Soft Tissue; Osteosarcomas; Chondrosarcoma, Grade 3; Chordoma; Angiosarcomas
Interventions: Other: Questionnaire
Sponsors: Hospices Civils de Lyon; Centre François Baclesse, Centre de lutte contre le cancer (CLCC)
Not yet recruiting -
A Phase II Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Posted: July 30th, 2024, 11:00pm UTC
Conditions: Leiomyosarcoma; Sarcoma
Interventions: Drug: all-trans retinoic acid; Drug: Cemiplimab; Procedure: Computed Tomography; Procedure: Magnetic resonance imaging
Sponsors: Gabriel Tinoco
Not yet recruiting -
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
Posted: July 30th, 2024, 11:00pm UTC
Conditions: Adult Pleomorphic Rhabdomyosarcoma; AJCC Grade 2 Sarcoma; AJCC Grade 3 Sarcoma; Alveolar Soft Part Sarcoma; Angiosarcoma; Clear Cell Sarcoma of Soft Tissue; Dedifferentiated Liposarcoma; Extraskeletal Ewing Sarcoma; Extraskeletal Myxoid Chondrosarcoma; Fibrosarcoma; Fibrosarcomatous Dermatofibrosarcoma Protuberans; Leiomyosarcoma; Malignant Peripheral Nerve Sheath Tumor; Myxofibrosarcoma; Pleomorphic Liposarcoma; Round Cell Sarcoma With EWSR1-non-ETS Fusion; Sarcoma; Soft Tissue Sarcoma; Soft Tissue Sarcoma of the Trunk and Extremities; Spindle Cell Sarcoma; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Synovial Sarcoma; Undifferentiated Pleomorphic Sarcoma
Interventions: Procedure: Biopsy; Procedure: Chest Computed Tomography; Procedure: Chest Radiography; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)
Not yet recruiting -
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
Posted: July 29th, 2024, 11:00pm UTC
Conditions: Leiomyosarcoma Uterus
Interventions: Drug: Doxorubicin; Drug: Trabectedin
Sponsors: UNICANCER; PharmaMar; Ligue contre le cancer, France; National Research Agency, France; University Hospital, Marseille; Institut Claudius Regaud; Institut Bergonié; Oncopole
Not yet recruiting -
Single High-dose Brachytherapy for Giant Osteosarcoma Masses
Posted: July 29th, 2024, 11:00pm UTC
Conditions: Osteosarcoma
Interventions: Radiation: brachytherapy
Sponsors: Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not yet recruiting -
The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions
Posted: July 25th, 2024, 11:00pm UTC
Conditions: Leiomyosarcoma
Interventions: Procedure: tru cut biopsy
Sponsors: Charles University, Czech Republic
Not yet recruiting -
Neurofibromatosis Type 1 Tumor Early Detection Study
Posted: July 23rd, 2024, 11:00pm UTC
Conditions: Neurofibromatosis Type 1; Neurofibromatosis 1; Plexiform Neurofibroma; Plexiform Neurofibromas; Malignant Peripheral Nerve Sheath Tumor; Malignant Peripheral Nerve Sheath Tumors; Atypical Neurofibroma
Interventions: Diagnostic Test: Liquid biopsy for MPNST development
Sponsors: David Miller
Recruiting -
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
Posted: July 23rd, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma
Interventions: Drug: Mitoxantrone Hydrochloride Liposome+Irinotecan+Vincristine; Drug: Temozolomide+Irinotecan+Vincristine
Sponsors: Yizhuo Zhang
Recruiting -
Cardiotoxic Effects of Chemotherapy in Patients With Sarcomas: A Two and Three-dimensional Echocardiographic Speckle Tracking Imaging Study
Posted: July 22nd, 2024, 11:00pm UTC
Conditions: Sarcoma
Interventions: Other: Non-Interventional Study
Sponsors: Mayo Clinic
Recruiting -
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Posted: July 18th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma; Doxorubicin; Radiotherapy
Interventions: Drug: Anlotinib
Sponsors: Guangdong Provincial People's Hospital
Not yet recruiting -
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Posted: July 18th, 2024, 11:00pm UTC
Conditions: Sarcoma; Cervical Cancer; Colon Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Hepatocellular Carcinoma; Breast Cancer; Gastric Cancer
Interventions: Biological: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors
Sponsors: GONGCHU Biotechnology Co., Ltd
Recruiting -
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
Posted: July 15th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma; Melanoma
Interventions: Drug: TQB2916 injection + doxorubicin hydrochloride for injection; Drug: TQB2916 injection+penpulimab injection
Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting -
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
Posted: July 15th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma
Interventions: Procedure: Computed Tomography; Radiation: Gallium Ga 68-HA-DOTA-TATE; Procedure: Positron Emission Tomography
Sponsors: Ohio State University Comprehensive Cancer Center
Recruiting -
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Posted: July 15th, 2024, 11:00pm UTC
Conditions: Neuroblastoma; Sarcoma; Osteosarcoma
Interventions: Drug: B7-H3CART Dose (Intravenous)
Sponsors: Stanford University
Recruiting -
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Posted: July 15th, 2024, 11:00pm UTC
Conditions: Febrile Neutropenia; Sarcoma; Doxorubicin Adverse Reaction; Hospitalization-Associated Infection
Interventions: Device: Acupuncture
Sponsors: Shaare Zedek Medical Center
Not yet recruiting -
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Posted: July 12th, 2024, 11:00pm UTC
Conditions: Advanced Soft Tissue Sarcoma; Dedifferentiated Liposarcoma; Leiomyosarcoma; Metastatic Soft Tissue Sarcoma; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Interventions: Drug: Abemaciclib; Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Docetaxel; Other: Fluorothymidine F-18; Drug: Gemcitabine; Procedure: Positron Emission Tomography
Sponsors: National Cancer Institute (NCI)
Not yet recruiting -
A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma
Posted: July 10th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma
Interventions: Combination Product: Aliya Pulse Electric Field sysem and pembrolizumab
Sponsors: Sarcoma Oncology Research Center, LLC
Not yet recruiting -
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
Posted: July 9th, 2024, 11:00pm UTC
Conditions: Osteosarcoma; Pulmonary Recurrence of Osteosarcoma
Interventions: Procedure: Surgical Resection; Radiation: Stereotactic Body Radiation Therapy (SBRT); Drug: Atezolizumab
Sponsors: Emory University; Genentech, Inc.
Not yet recruiting -
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
Posted: July 1st, 2024, 11:00pm UTC
Conditions: Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Fallopian Tube Carcinosarcoma; Recurrent Female Reproductive System Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Ovarian Carcinosarcoma; Recurrent Platinum-Resistant Fallopian Tube Carcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Carcinosarcoma; Refractory Fallopian Tube Carcinoma; Refractory Female Reproductive System Carcinoma; Refractory Ovarian Carcinoma; Refractory Primary Peritoneal Carcinoma
Interventions: Biological: Autologous MUC1-activated T-cells; Drug: Bendamustine; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Cyclophosphamide; Procedure: Echocardiography; Procedure: Leukapheresis; Procedure: Magnetic Resonance Imaging; Procedure: Multigated Acquisition Scan; Procedure: Positron Emission Tomography
Sponsors: Mayo Clinic
Not yet recruiting -
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Posted: July 1st, 2024, 11:00pm UTC
Conditions: Sarcoma
Interventions: Other: Surveys; Other: Blood Collection; Other: Saliva Collection; Other: Urine Collection; Other: Stool Collection; Other: Tissue collection; Other: Physical Activity Monitoring
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Recruiting -
Kaposi Sarcoma Chemotherapy and Research (KS-CARE)
Posted: June 28th, 2024, 11:00pm UTC
Conditions: Kaposi Sarcoma; HIV
Interventions: Drug: standard of care chemotherapy
Sponsors: UNC Lineberger Comprehensive Cancer Center; National Center for Advancing Translational Sciences (NCATS)
Not yet recruiting -
High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma
Posted: June 28th, 2024, 11:00pm UTC
Conditions: Sarcoma,Soft Tissue; Sarcoma Retroperitoneal
Interventions: Diagnostic Test: High-intensity radiological surveillance; Diagnostic Test: Lower-intensity radiological surveillance
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Birmingham; University Hospital Birmingham NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University Hospital Padova; Campus Bio-Medico University; The Netherlands Cancer Institute; KU Leuven; Heidelberg University; Dana-Farber/Brigham and Women's Cancer Center; Emory University; Mayo Clinic; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; The Cleveland Clinic; M.D. Anderson Cancer Center; University of Southern California; Ohio State University; Ottawa Hospital Research Institute; McGill University; Peter MacCallum Cancer Centre, Australia; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting -
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Posted: June 26th, 2024, 11:00pm UTC
Conditions: Metastatic Soft-tissue Sarcoma
Interventions: Drug: Cyclophosphamide; Drug: T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy
Sponsors: M.D. Anderson Cancer Center
Not yet recruiting -
Phase 2 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas
Posted: June 26th, 2024, 11:00pm UTC
Conditions: Sarcoma
Interventions: Drug: Administration of L-TC; Radiation: HFRT alone
Sponsors: Institut de cancérologie Strasbourg Europe; LEAF4Life, Inc.
Not yet recruiting -
Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Posted: June 18th, 2024, 11:00pm UTC
Conditions: Atypical Teratoid/Rhabdoid Tumor; Neuroblastoma Recurrent; Embryonal Tumor With Multilayered Rosettes; DIPG Brain Tumor; Ewing Sarcoma; Osteosarcoma Recurrent
Interventions: Drug: Difluoromethylornithine (DFMO); Drug: AMXT-1501 Dicaprate
Sponsors: Milton S. Hershey Medical Center; Aminex Therapeutics, Inc.
Not yet recruiting -
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Posted: June 13th, 2024, 11:00pm UTC
Conditions: Rhabdomyosarcoma; Pediatric Cancer
Interventions: Drug: Pucotenlimab
Sponsors: Sun Yat-sen University
Recruiting -
Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor
Posted: June 13th, 2024, 11:00pm UTC
Conditions: Desmoplastic Small Round Cell Tumor; Synovial Sarcoma
Interventions: Drug: Signifor
Sponsors: University Hospital Heidelberg
Not yet recruiting -
Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study
Posted: June 11th, 2024, 11:00pm UTC
Conditions: Ewing Sarcoma; Risk Stratification
Interventions: Drug: cyclophosphamide, adriamycin, vincristine，Ifosfamide，etoposide
Sponsors: Yizhuo Zhang
Active, not recruiting -
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Posted: June 6th, 2024, 11:00pm UTC
Conditions: Kaposi Sarcoma
Interventions: Drug: Propranolol Hydrochloride
Sponsors: Washington University School of Medicine
Not yet recruiting -
A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma
Posted: June 3rd, 2024, 11:00pm UTC
Conditions: Refractory Neuroblastoma; Soft Tissue Cancer
Interventions: Drug: HITS; Drug: Naxitamab + GM-CSF cycles; Drug: NICE
Sponsors: Fundació Sant Joan de Déu
Completed -
TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors
Posted: June 3rd, 2024, 11:00pm UTC
Conditions: Osteosarcoma; Other Solid Tumors
Interventions: Drug: 1200mg of TQB2928 injection+Anlotinib; Drug: 1800mg of TQB2928 injection+Anlotinib
Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Recruiting -
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
Posted: May 31st, 2024, 11:00pm UTC
Conditions: Abdominopelvic Sarcomas
Interventions: Radiation: Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy
Sponsors: Jonsson Comprehensive Cancer Center
Recruiting -
Genomic Risk in Retroperitoneal Sarcoma
Posted: May 31st, 2024, 11:00pm UTC
Conditions: Retroperitoneal Liposarcoma; Soft Tissue Sarcoma
Interventions: Other: Biospecimen sample collection during standard-of-care surgery
Sponsors: Fox Chase Cancer Center
Recruiting -
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Posted: May 21st, 2024, 11:00pm UTC
Conditions: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Undifferentiated Pleomorphic Sarcoma
Interventions: Procedure: Biospecimen Collection; Procedure: Diagnostic Imaging; Drug: Doxorubicin; Procedure: Echocardiography; Procedure: Multigated Acquisition Scan; Biological: Pembrolizumab
Sponsors: National Cancer Institute (NCI)
Not yet recruiting -
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
Posted: May 16th, 2024, 11:00pm UTC
Conditions: Advanced Cancer; Stage IV Solid Tumor Cancer; Stage IV Sarcoma of Bone; Stage IV Lymphoma; Stage IV Melanoma; Endocrine Cancer
Interventions: Drug: Psilocybin
Sponsors: University Health Network, Toronto
Not yet recruiting -
BTX-A51 in Patients With Liposarcoma
Posted: May 15th, 2024, 11:00pm UTC
Conditions: Liposarcoma; Recurrent Liposarcoma; Metastatic Liposarcoma; Unresectable Liposarcoma; MDM2 Gene Amplification
Interventions: Drug: BTX-A51
Sponsors: Michael Wagner; Edgewood Oncology Inc.
Not yet recruiting -
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Posted: May 14th, 2024, 11:00pm UTC
Conditions: Head and Neck Squamous Cell Carcinoma; Soft Tissue Sarcoma
Interventions: Biological: Pembrolizumab; Combination Product: MK-0482 + Pembrolizumab; Combination Product: MK-4830 + Pembrolizumab
Sponsors: Presage Biosciences; Merck Sharp & Dohme LLC
Completed -
IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma
Posted: May 14th, 2024, 11:00pm UTC
Conditions: Refractory Osteosarcoma; Recurrent Osteosarcoma
Interventions: Biological: IM83 CAR-T Cells
Sponsors: Beijing Immunochina Medical Science & Technology Co., Ltd.; Guangdong Provincial People's Hospital
Not yet recruiting -
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Posted: May 10th, 2024, 11:00pm UTC
Conditions: Bone Sarcoma; Soft Tissue Sarcoma
Interventions: Other: Non-Interventional Study
Sponsors: Mayo Clinic
Recruiting -
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Posted: May 10th, 2024, 11:00pm UTC
Conditions: Epithelioid Hemangioendothelioma; Sarcoma,Soft Tissue
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; EHE Rare Cancer Charity UK
Recruiting -
Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience
Posted: May 2nd, 2024, 11:00pm UTC
Conditions: Primary Retroperitoneal Sarcoma
Interventions: Other: WANG DAORONG
Sponsors: Northern Jiangsu People's Hospital
Completed -
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Posted: May 1st, 2024, 11:00pm UTC
Conditions: B-cell Acute Lymphoblastic Leukemia; Diffuse Large B-cell Lymphoma; Burkitt Lymphoma; Neuroblastoma; Ewing Sarcoma
Interventions: Biological: Zilovertamab vedotin
Sponsors: Merck Sharp & Dohme LLC
Not yet recruiting -
Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer
Posted: May 1st, 2024, 11:00pm UTC
Conditions: Platinum-Refractory Fallopian Tube Carcinoma; Platinum-Refractory Ovarian Carcinoma; Platinum-Refractory Primary Peritoneal Carcinoma; Recurrent Fallopian Tube Adenocarcinoma; Recurrent Fallopian Tube Carcinosarcoma; Recurrent Fallopian Tube Clear Cell Adenocarcinoma; Recurrent Fallopian Tube High Grade Serous Adenocarcinoma; Recurrent Fallopian Tube Undifferentiated Carcinoma; Recurrent High Grade Endometrioid Adenocarcinoma; Recurrent Ovarian Adenocarcinoma; Recurrent Ovarian Carcinosarcoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovarian High Grade Serous Adenocarcinoma; Recurrent Ovarian Seromucinous Carcinoma; Recurrent Ovarian Undifferentiated Carcinoma; Recurrent Platinum-Resistant Fallopian Tube Carcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma; Recurrent Platinum-Resistant Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Adenocarcinoma; Recurrent Primary Peritoneal Carcinosarcoma; Recurrent Primary Peritoneal Clear Cell Adenocarcinoma; Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma; Recurrent Primary Peritoneal Undifferentiated Carcinoma
Interventions: Biological: Bevacizumab; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Paclitaxel; Drug: Tolinapant
Sponsors: National Cancer Institute (NCI)
Not yet recruiting -
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
Posted: April 29th, 2024, 11:00pm UTC
Conditions: Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8; Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8; Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
Interventions: Other: Clinical Observation; Procedure: Computed Tomography; Radiation: External Beam Radiation Therapy; Procedure: High-Dose-Rate Vaginal Brachytherapy; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Procedure: X-Ray Imaging
Sponsors: NRG Oncology; National Cancer Institute (NCI); Canadian Cancer Trials Group
Suspended -
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Posted: April 29th, 2024, 11:00pm UTC
Conditions: Dedifferentiated Liposarcoma
Interventions: Drug: Pemigatinib; Drug: Retifanlimab
Sponsors: Lund University Hospital
Not yet recruiting -
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Posted: April 29th, 2024, 11:00pm UTC
Conditions: Sarcoma, Ewing; Chondrosarcoma; Osteosarcoma; Fibrous Histiocytoma; Fibrosarcoma
Interventions: Device: 3D Printed Anatomic Model; Diagnostic Test: CT/MRI
Sponsors: Ricoh USA, Inc.
Recruiting -
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Posted: April 26th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma Adult
Interventions: Other: Blood and tissue collection for immunological studies, advanced imaging.; Other: neoadjuvant Therapy
Sponsors: University Hospital Tuebingen
Recruiting -
Upfront Surgical Resection for Osteosarcoma
Posted: April 25th, 2024, 11:00pm UTC
Conditions: Osteosarcoma
Interventions: Other: Questionnaire
Sponsors: Montefiore Medical Center
Recruiting -
Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma
Posted: April 25th, 2024, 11:00pm UTC
Conditions: Unresectable or Metastatic Sarcoma
Interventions: Drug: LTC004
Sponsors: Letolab
Not yet recruiting -
Natural History Study of Kaposi Sarcoma
Posted: April 19th, 2024, 11:00pm UTC
Conditions: Kaposi Sarcoma; HIV
Sponsors: National Cancer Institute (NCI)
Not yet recruiting -
Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
Posted: April 19th, 2024, 11:00pm UTC
Conditions: Angiosarcoma
Interventions: Other: Observational
Sponsors: Italian Sarcoma Group
Recruiting -
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Posted: April 17th, 2024, 11:00pm UTC
Conditions: Cancer; Breast Cancer; Colorectal Cancer; Sarcoma; Lymphoma; Testicular Cancer
Interventions: Behavioral: AYA Educational Information; Behavioral: AYA STEPS
Sponsors: Duke University
Not yet recruiting -
Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma
Posted: April 17th, 2024, 11:00pm UTC
Conditions: Advanced Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma (UPS); Myxofibrosarcoma (MFS)
Interventions: Drug: Brigimadlin; Drug: Ezabenlimab; Drug: Gemcitabine; Drug: Docetaxel
Sponsors: Boehringer Ingelheim
Not yet recruiting -
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
Posted: April 16th, 2024, 11:00pm UTC
Conditions: Advanced Soft-tissue Sarcoma
Interventions: Drug: Cadonilimab; Drug: Adriamycin
Sponsors: Wuhan Union Hospital, China; Sun Yat-sen University; Xiangya Hospital of Central South University; Yunnan Cancer Hospital; The Affiliated Hospital Of Guizhou Medical University; First Affiliated Hospital of Guangxi Medical University
Not yet recruiting -
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
Posted: April 12th, 2024, 11:00pm UTC
Conditions: Advanced Cancer; Advanced Solid Tumor; Lymphoma, Hodgkin; Central Nervous System Tumor; Sarcoma; Germ Cell Tumor; Pediatric Cancer
Interventions: Dietary Supplement: Ocoxin Oral solution
Sponsors: Catalysis SL
Not yet recruiting -
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004)
Posted: April 3rd, 2024, 11:00pm UTC
Conditions: Non-small Cell Lung Cancer
Interventions: Drug: MK-1084; Other: Placebo; Biological: Pembrolizumab
Sponsors: Merck Sharp & Dohme LLC
Not yet recruiting -
Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
Posted: April 2nd, 2024, 11:00pm UTC
Conditions: Osteosarcoma; Osteosarcoma in Children; Osteosarcoma in Adolescents and Young Adults
Interventions: Drug: Cabozantinib; Other: Best Supportive Care (BSC); Other: Best Supportive Care (BSC)
Sponsors: Ipsen
Not yet recruiting -
Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Posted: April 1st, 2024, 11:00pm UTC
Conditions: Ewing Sarcoma
Interventions: Drug: Irinotecan Hydrochloride Liposome Injection
Sponsors: Peking University People's Hospital; Peking University Shougang Hospital; Shandong Cancer Hospital and Institute
Recruiting -
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Posted: March 28th, 2024, 11:00pm UTC
Conditions: Solid Tumor
Interventions: Drug: ACTM-838
Sponsors: Actym Therapeutics, Inc.
Not yet recruiting -
tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
Posted: March 27th, 2024, 11:00pm UTC
Conditions: Cancer; Lung Cancer; Colo-rectal Cancer; Pancreas Cancer; Soft Tissue Sarcoma
Interventions: Drug: Tislelizumab; Other: Blood sampling; Drug: Placebo
Sponsors: Gustave Roussy, Cancer Campus, Grand Paris; BeiGene; C2i Genomics
Not yet recruiting -
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Posted: March 27th, 2024, 11:00pm UTC
Conditions: Pancreatic Adenocarcinoma; Ampulla of Vater Carcinoma; Adrenocortical Carcinoma; Neuroendocrine Carcinoma; Soft Tissue Sarcoma; Small Bowel Adenocarcinoma; Duodenum Adenocarcinoma; Gastric Adenocarcinoma
Interventions: Drug: Dostarlimab; Drug: Chemotherapy
Sponsors: UNICANCER; National Cancer Institute, France; GlaxoSmithKline
Not yet recruiting -
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
Posted: March 25th, 2024, 11:00pm UTC
Conditions: Retroperitoneal Sarcoma
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Radiation: Intensity-Modulated Radiation Therapy; Procedure: Resection; Radiation: Spatially-fractionated Radiation Therapy
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet recruiting -
Donor Site Morbidity After Free Vascularized Fibular Graft
Posted: March 22nd, 2024, 11:00pm UTC
Conditions: Osteosarcoma
Interventions: Radiation: Xray
Sponsors: Assiut University
Recruiting -
Outcomes Comparison Between Bone Resection and Subperiosteal Dissection for Specific Type of Soft Tissue Sarcoma
Posted: March 19th, 2024, 11:00pm UTC
Conditions: Soft Tissue Sarcoma; Cortical Contact
Interventions: Procedure: bone resection; Procedure: subperiosteal excision
Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed -
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Posted: March 13th, 2024, 11:00pm UTC
Conditions: Leiomyosarcoma; Soft-tissue Sarcomas
Interventions: Drug: Gemcitabine; Drug: Nab-Sirolimus
Sponsors: M.D. Anderson Cancer Center; Aadi Bioscience
Not yet recruiting -
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Posted: March 7th, 2024, 1:00am UTC
Conditions: Metastatic Sarcoma; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer; Colorectal Cancer; Sarcoma
Interventions: Combination Product: 64Cu-LNTH-1363S
Sponsors: Lantheus Medical Imaging
Not yet recruiting -
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Posted: March 7th, 2024, 1:00am UTC
Conditions: Ovarian Carcinoma; Fallopian Tube Carcinoma; Peritoneal Carcinoma; Endometrial Cancer; Adenocarcinoma of Lung; Triple Negative Breast Cancer; Liposarcoma; Leiomyosarcoma; Mesothelioma, Malignant; Adenocarcinoma - Gastroesophageal Junction (GEJ); Adenocarcinoma of the Stomach; Melanoma, Malignant; Renal Cell Carcinoma
Interventions: Biological: NM32-2668
Sponsors: Numab Therapeutics AG
Recruiting -
Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
Posted: March 4th, 2024, 1:00am UTC
Conditions: Sarcoma; Intracranial Neoplasm; Pelvic Bone Neoplasm
Interventions: Device: 3D printer applications
Sponsors: Kathleen McGreevy
Recruiting -
AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
Posted: February 29th, 2024, 1:00am UTC
Conditions: Phyllodes Breast Tumor; Artificial Intelligence; Multiomics; Prognostic Cancer Model; Diagnosis
Interventions: Diagnostic Test: imaging
Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Sun Yat-sen University; Peking University Shenzhen Hospital; Guangdong Provincial Maternal and Child Health Hospital; The Third Affiliated Hospital of Guangzhou Medical University
Recruiting -
Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Undergoing Surgical Treatment: Observational Study
Posted: February 28th, 2024, 1:00am UTC
Conditions: Sarcoma
Interventions: Other: survey
Sponsors: Fondazione Policlinico Universitario Campus Bio-Medico; Fondazione Don Carlo Gnocchi Onlus
Recruiting -
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Posted: February 26th, 2024, 1:00am UTC
Conditions: Leiomyosarcoma; Liposarcoma; Synovial Sarcoma; Angiosarcoma; Undifferentiated Pleomorphic Sarcoma; Epithelioid Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Fibrosarcoma; Pleomorphic Rhabdomyosarcoma; Endometrial Stromal Sarcoma; Desmoplastic Small Round Cell Tumor
Interventions: Biological: MASCT-I; Drug: Doxorubicin; Drug: Ifosfamide
Sponsors: HRYZ Biotech Co.
Not yet recruiting -
A Phase 0 Multicenter Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Posted: February 23rd, 2024, 1:00am UTC
Conditions: Head and Neck Squamous Cell Carcinoma; Soft Tissue Sarcoma Adult; Triple Negative Breast Cancer
Interventions: Drug: PBA-0405
Sponsors: Pure Biologics S.A.; Presage Biosciences
Not yet recruiting -
YASU Research Registry: For Young Adults With Cancer
Posted: February 23rd, 2024, 1:00am UTC
Conditions: Cancer; Leukemia; Sarcoma; Germ Cell Cancer; Lymphoma; Colorectal Cancer; Melanoma; Breast Cancer
Sponsors: Young Adult Survivors United; Staunton Farm Foundation; Elsie H. Hillman Foundation
Not yet recruiting -
BostonGene and Exigent Genomic INsight Study
Posted: February 22nd, 2024, 1:00am UTC
Conditions: Breast Cancer; Non-small Cell Lung Cancer; Melanoma; Sarcoma
Sponsors: BostonGene; Exigent
Not yet recruiting -
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
Posted: February 19th, 2024, 1:00am UTC
Conditions: Soft Tissue Sarcoma
Sponsors: Power Life Sciences Inc.
Not yet recruiting
1
2